These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 28139693

  • 21. Exome-based genome-wide association study and risk assessment using genetic risk score to prostate cancer in the Korean population.
    Oh JJ, Lee SJ, Hwang JY, Kim D, Lee SE, Hong SK, Ho JN, Yoon S, Sung J, Kim WJ, Byun SS.
    Oncotarget; 2017 Jul 04; 8(27):43934-43943. PubMed ID: 28380453
    [Abstract] [Full Text] [Related]

  • 22. Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).
    Jin G, Lu L, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Cannon-Albright LA, Camp NJ, Teerlink CC, Fitzgerald LM, Stanford JL, Wiley KE, Isaacs SD, Walsh PC, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, Easton D, Kote-Jarai Z, Guy M, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O, Thibodeau SN, McDonnell SK, Schaid DJ, Wiklund F, Grönberg H, Emanuelsson M, Whittemore AS, Oakley-Girvan I, Hsieh CL, Wahlfors T, Tammela T, Schleutker J, Catalona WJ, Zheng SL, Ostrander EA, Isaacs WB, Xu J, International Consortium for Prostate Cancer Genetics.
    Hum Genet; 2012 Jul 04; 131(7):1095-103. PubMed ID: 22198737
    [Abstract] [Full Text] [Related]

  • 23. Genetic correction of PSA values using sequence variants associated with PSA levels.
    Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson I, Arinbjarnarson S, Agnarsson BA, Benediktsdottir KR, Isaksson HJ, Kostic JP, Gudjonsson SA, Stacey SN, Gylfason A, Sigurdsson A, Holm H, Bjornsdottir US, Eyjolfsson GI, Navarrete S, Fuertes F, Garcia-Prats MD, Polo E, Checherita IA, Jinga M, Badea P, Aben KK, Schalken JA, van Oort IM, Sweep FC, Helfand BT, Davis M, Donovan JL, Hamdy FC, Kristjansson K, Gulcher JR, Masson G, Kong A, Catalona WJ, Mayordomo JI, Geirsson G, Einarsson GV, Barkardottir RB, Jonsson E, Jinga V, Mates D, Kiemeney LA, Neal DE, Thorsteinsdottir U, Rafnar T, Stefansson K.
    Sci Transl Med; 2010 Dec 15; 2(62):62ra92. PubMed ID: 21160077
    [Abstract] [Full Text] [Related]

  • 24. Polymorphisms in the prostate-specific antigen gene promoter do not predict serum prostate-specific antigen levels in African-American men.
    Beebe-Dimmer JL, Lange LA, Cain JE, Lewis RC, Ray AM, Sarma AV, Lange EM, Cooney KA.
    Prostate Cancer Prostatic Dis; 2006 Dec 15; 9(1):50-5. PubMed ID: 16247489
    [Abstract] [Full Text] [Related]

  • 25. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.
    Cramer SD, Chang BL, Rao A, Hawkins GA, Zheng SL, Wade WN, Cooke RT, Thomas LN, Bleecker ER, Catalona WJ, Sterling DA, Meyers DA, Ohar J, Xu J.
    J Natl Cancer Inst; 2003 Jul 16; 95(14):1044-53. PubMed ID: 12865450
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer.
    Tosoian J, Loeb S.
    ScientificWorldJournal; 2010 Oct 01; 10():1919-31. PubMed ID: 20890581
    [Abstract] [Full Text] [Related]

  • 28. Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels.
    Penney KL, Schumacher FR, Kraft P, Mucci LA, Sesso HD, Ma J, Niu Y, Cheong JK, Hunter DJ, Stampfer MJ, Hsu SI.
    Carcinogenesis; 2011 Jun 01; 32(6):853-9. PubMed ID: 21421545
    [Abstract] [Full Text] [Related]

  • 29. Prostate Cancer Risk-Associated Single-Nucleotide Polymorphism Affects Prostate-Specific Antigen Glycosylation and Its Function.
    Srinivasan S, Stephens C, Wilson E, Panchadsaram J, DeVoss K, Koistinen H, Stenman UH, Brook MN, Buckle AM, Klein RJ, Lilja H, Clements J, Batra J, Practical Consortium.
    Clin Chem; 2019 Jan 01; 65(1):e1-e9. PubMed ID: 30538125
    [Abstract] [Full Text] [Related]

  • 30. Susceptibility loci associations with prostate cancer risk in northern Chinese men.
    Wang NN, Xu Y, Yang K, Wei D, Zhang YG, Liu M, Shi XH, Liang SY, Sun L, Zhu XQ, Yang YG, Tang L, Zhao CX, Wang X, Chen X, Hui J, Zhang YH, Zhu L, Yang F, Zhang YR, Yang Z, Wang JY.
    Asian Pac J Cancer Prev; 2013 Jan 01; 14(5):3075-8. PubMed ID: 23803082
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Polymorphisms influencing prostate-specific antigen concentration may bias genome-wide association studies on prostate cancer.
    Dluzniewski PJ, Xu J, Ruczinski I, Isaacs WB, Platz EA.
    Cancer Epidemiol Biomarkers Prev; 2015 Jan 01; 24(1):88-93. PubMed ID: 25352524
    [Abstract] [Full Text] [Related]

  • 33. Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians.
    Shan J, Al-Rumaihi K, Rabah D, Al-Bozom I, Kizhakayil D, Farhat K, Al-Said S, Kfoury H, Dsouza SP, Rowe J, Khalak HG, Jafri S, Aigha II, Chouchane L.
    J Transl Med; 2013 May 13; 11():121. PubMed ID: 23668334
    [Abstract] [Full Text] [Related]

  • 34. A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.
    Nordström T, Aly M, Eklund M, Egevad L, Grönberg H.
    Eur Urol; 2014 Jun 13; 65(6):1184-90. PubMed ID: 23891454
    [Abstract] [Full Text] [Related]

  • 35. Prostate cancer risk-associated genetic markers and their potential clinical utility.
    Xu J, Sun J, Zheng SL.
    Asian J Androl; 2013 May 13; 15(3):314-22. PubMed ID: 23564047
    [Abstract] [Full Text] [Related]

  • 36. Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men.
    Liu F, Hsing AW, Wang X, Shao Q, Qi J, Ye Y, Wang Z, Chen H, Gao X, Wang G, Chu LW, Ding Q, OuYang J, Gao X, Huang Y, Chen Y, Gao YT, Zhang ZF, Rao J, Shi R, Wu Q, Wang M, Zhang Z, Zhang Y, Jiang H, Zheng J, Hu Y, Guo L, Lin X, Tao S, Jin G, Sun J, Lu D, Zheng SL, Sun Y, Mo Z, Xu J.
    Cancer Sci; 2011 Oct 13; 102(10):1916-20. PubMed ID: 21756274
    [Abstract] [Full Text] [Related]

  • 37. A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.
    Hoffmann TJ, Van Den Eeden SK, Sakoda LC, Jorgenson E, Habel LA, Graff RE, Passarelli MN, Cario CL, Emami NC, Chao CR, Ghai NR, Shan J, Ranatunga DK, Quesenberry CP, Aaronson D, Presti J, Wang Z, Berndt SI, Chanock SJ, McDonnell SK, French AJ, Schaid DJ, Thibodeau SN, Li Q, Freedman ML, Penney KL, Mucci LA, Haiman CA, Henderson BE, Seminara D, Kvale MN, Kwok PY, Schaefer C, Risch N, Witte JS.
    Cancer Discov; 2015 Aug 13; 5(8):878-91. PubMed ID: 26034056
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Genetic predisposition to prostate cancer.
    Benafif S, Eeles R.
    Br Med Bull; 2016 Dec 13; 120(1):75-89. PubMed ID: 27941040
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.